These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26271463)

  • 1. Non-steroidal anti-inflammatory drugs and risk of cerebrovascular events in patients with osteoarthritis: a nested case-control study.
    Lapi F; Piccinni C; Simonetti M; Levi M; Lora Aprile P; Cricelli I; Cricelli C; Fanelli A
    Intern Emerg Med; 2016 Feb; 11(1):49-59. PubMed ID: 26271463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Acute Cerebrovascular and Cardiovascular Events Among Users of Acetaminophen or an Acetaminophen-Codeine Combination in a Cohort of Patients with Osteoarthritis: A Nested Case-Control Study.
    Roberto G; Simonetti M; Piccinni C; Lora Aprile P; Cricelli I; Fanelli A; Cricelli C; Lapi F
    Pharmacotherapy; 2015 Oct; 35(10):899-909. PubMed ID: 26497476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study.
    Arfè A; Scotti L; Varas-Lorenzo C; Nicotra F; Zambon A; Kollhorst B; Schink T; Garbe E; Herings R; Straatman H; Schade R; Villa M; Lucchi S; Valkhoff V; Romio S; Thiessard F; Schuemie M; Pariente A; Sturkenboom M; Corrao G;
    BMJ; 2016 Sep; 354():i4857. PubMed ID: 27682515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis.
    Dubreuil M; Louie-Gao Q; Peloquin CE; Choi HK; Zhang Y; Neogi T
    Ann Rheum Dis; 2018 Aug; 77(8):1137-1142. PubMed ID: 29674321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
    Turajane T; Wongbunnak R; Patcharatrakul T; Ratansumawong K; Poigampetch Y; Songpatanasilp T
    J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S19-26. PubMed ID: 20128070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S401-13. PubMed ID: 12416790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of NSAIDS on mortality and the effect of preexisting coronary artery disease in US veterans.
    Lee TA; Bartle B; Weiss KB
    Am J Med; 2007 Jan; 120(1):98.e9-16. PubMed ID: 17208086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs and the risk of ischemic stroke: a nested case-control study.
    Andersohn F; Schade R; Suissa S; Garbe E
    Stroke; 2006 Jul; 37(7):1725-30. PubMed ID: 16728684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of upper gastrointestinal complications in a cohort of users of nimesulide and other nonsteroidal anti-inflammatory drugs in Friuli Venezia Giulia, Italy.
    Castellsague J; Pisa F; Rosolen V; Drigo D; Riera-Guardia N; Giangreco M; Clagnan E; Tosolini F; Zanier L; Barbone F; Perez-Gutthann S
    Pharmacoepidemiol Drug Saf; 2013 Apr; 22(4):365-75. PubMed ID: 23229866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis.
    Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ
    Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
    Hippisley-Cox J; Coupland C; Logan R
    BMJ; 2005 Dec; 331(7528):1310-6. PubMed ID: 16322018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-aspirin NSAIDs, cyclooxygenase-2 inhibitors and risk for cardiovascular events-stroke, acute myocardial infarction, and death from coronary heart disease.
    Roumie CL; Choma NN; Kaltenbach L; Mitchel EF; Arbogast PG; Griffin MR
    Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1053-63. PubMed ID: 19637402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of topical diclofenac sodium 1% gel for osteoarthritis in seniors and patients with comorbidities.
    Baraf HS; Gold MS; Petruschke RA; Wieman MS
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):47-60. PubMed ID: 22264852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic Use and Risk for Acute Coronary Events in Patients With Osteoarthritis: A Population-based, Nested Case-control Study.
    Pontes C; Marsal JR; Elorza JM; Aragón M; Prieto-Alhambra D; Morros R
    Clin Ther; 2018 Feb; 40(2):270-283. PubMed ID: 29398161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study.
    Chang CH; Shau WY; Kuo CW; Chen ST; Lai MS
    Stroke; 2010 Sep; 41(9):1884-90. PubMed ID: 20671253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community.
    Mangoni AA; Woodman RJ; Gilbert AL; Knights KM
    Pharmacoepidemiol Drug Saf; 2010 May; 19(5):490-8. PubMed ID: 20437458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk.
    Solomon DH; Avorn J; Stürmer T; Glynn RJ; Mogun H; Schneeweiss S
    Arthritis Rheum; 2006 May; 54(5):1378-89. PubMed ID: 16645966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acute myocardial infarction during use of individual NSAIDs: A nested case-control study from the SOS project.
    Masclee GMC; Straatman H; Arfè A; Castellsague J; Garbe E; Herings R; Kollhorst B; Lucchi S; Perez-Gutthann S; Romio S; Schade R; Schink T; Schuemie MJ; Scotti L; Varas-Lorenzo C; Valkhoff VE; Villa M; Sturkenboom MCJM
    PLoS One; 2018; 13(11):e0204746. PubMed ID: 30383755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the incidence rates of thromboembolic events reported for patients prescribed celecoxib and meloxicam in general practice in England using Prescription-Event Monitoring (PEM) data.
    Layton D; Hughes K; Harris S; Shakir SA
    Rheumatology (Oxford); 2003 Nov; 42(11):1354-64. PubMed ID: 12867585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.